Literature DB >> 20088606

Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.

Orsolya Polgar1, Caterina Ierano, Akina Tamaki, Bradford Stanley, Yvona Ward, Di Xia, Nadya Tarasova, Robert W Robey, Susan E Bates.   

Abstract

ABCG2 is an ATP-binding cassette half-transporter important in normal tissue protection, drug distribution, and excretion. ABCG2 requires homodimerization for function, though the mechanism for dimerization has not been elucidated. We conducted mutational analysis of threonine 402, three residues from the GXXXG motif in TM1, to study its potential role in ABCG2 dimerization (TXXXGXXXG). Single mutations to leucine (T402L) or arginine (T402R) did not have a significant impact on the ABCG2 protein. On the other hand, combining the T402 mutations with the GXXXG glycine to leucine mutations (T402L/G406L/G410L and T402R/G406L/G410L) resulted in a substantially reduced level of expression, altered glycosylation, degradation by a proteosome-independent pathway, and partial retention in the endoplasmic reticulum as suggested by immunostaining, Endo H sensitivity, and MG132 and bafilomycin failed effect. The T402L/G406L/G410L mutant when incubated with the ABCG2 substrate MX showed a shift on immunoblot analysis to the band representing the fully mature glycoprotein. The T402R/G406L/G410L mutant carrying the more drastic substitution was found to primarily localize intracellularly. The same set of mutations also displayed impaired dimerization in the TOXCAT assay for TM1 compared to that of the wild type. Homology modeling of ABCG2 places the TXXXGXXXG motif at the dimer interface. These studies are consistent with a role for the extended TXXXGXXXG motif in ABCG2 folding, processing, and/or dimerization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088606      PMCID: PMC2836409          DOI: 10.1021/bi902085q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.

Authors:  Ulla Henriksen; Jacob U Fog; Thomas Litman; Ulrik Gether
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

2.  Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.

Authors:  R L Dormer; C M Harris; Z Clark; M M C Pereira; I J M Doull; C Norez; F Becq; M A McPherson
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

3.  Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.

Authors:  Kumie Kage; Toshiro Fujita; Yoshikazu Sugimoto
Journal:  Cancer Sci       Date:  2005-12       Impact factor: 6.716

4.  TOXCAT: a measure of transmembrane helix association in a biological membrane.

Authors:  W P Russ; D M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

5.  Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Authors:  K Miyake; L Mickley; T Litman; Z Zhan; R Robey; B Cristensen; M Brangi; L Greenberger; M Dean; T Fojo; S E Bates
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

6.  The dimerization motif of the glycophorin A transmembrane segment in membranes: importance of glycine residues.

Authors:  B Brosig; D Langosch
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

7.  Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Authors:  M Maliepaard; M A van Gastelen; L A de Jong; D Pluim; R C van Waardenburg; M C Ruevekamp-Helmers; B G Floot; J H Schellens
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

8.  N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.

Authors:  Ndeye K Diop; Christine A Hrycyna
Journal:  Biochemistry       Date:  2005-04-12       Impact factor: 3.162

9.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

Authors:  R Allikmets; L M Schriml; A Hutchinson; V Romano-Spica; M Dean
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

10.  Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system.

Authors:  Kanako Wakabayashi; Hiroshi Nakagawa; Tatsuhiko Adachi; Isao Kii; Eiry Kobatake; Akira Kudo; Toshihisa Ishikawa
Journal:  J Exp Ther Oncol       Date:  2006
View more
  24 in total

1.  Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Authors:  Kenneth K W To; Brian Tomlinson
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 2.  Genetics of hyperuricemia and gout: implications for the present and future.

Authors:  Ronald L George; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

Review 3.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

4.  Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.

Authors:  Zhanglin Ni; Zsolt Bikadi; Xiaokun Cai; Mark F Rosenberg; Qingcheng Mao
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

Review 5.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

Review 6.  Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-09-19       Impact factor: 4.009

7.  Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.

Authors:  Zhanglin Ni; Zsolt Bikadi; Diana L Shuster; Chunsheng Zhao; Mark F Rosenberg; Qingcheng Mao
Journal:  Biochemistry       Date:  2011-08-26       Impact factor: 3.162

Review 8.  The challenge of exploiting ABCG2 in the clinic.

Authors:  Robert W Robey; Caterina Ierano; Zhirong Zhan; Susan E Bates
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

9.  Screening for transmembrane association in divisome proteins using TOXGREEN, a high-throughput variant of the TOXCAT assay.

Authors:  Claire R Armstrong; Alessandro Senes
Journal:  Biochim Biophys Acta       Date:  2016-07-22

Review 10.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.